Abstract
The emphasis of this chapter is on the mechanisms and functional significance of the interaction of neuropeptides with the putative neurotransmitter dopamine in the central nervous system (CNS). Accumulating evidence supports the contention that these interactions are of physiological importance and have added a novel dimension to our concepts of the pathophysiology of psychiatric disorders and the mechanisms of psychotropic drug action. Primary emphasis has been placed on findings from our laboratories and those of others concerning interactions between the tridecapeptide neurotensin (NT) and dopamine neurons. Where appropriate, the influence of other neuropeptides on dopamine mechanisms are discussed. We (Nemeroff et al., 1982a, 1983a, 1984) and others (Goedert, 1984) have previously reviewed the neuropharmacological, neuroanatomical and neurochemical literature supporting a functional interaction between NT-containing and dopamine-containing cells in the CNS and the interested reader is referred to these articles for a more comprehensive review than is intended here. The major objective of this chapter is to integrate recent data concerning the molecular basis of NT-dopamine interactions into the developing concept of the functional significance of such interactions.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Agnati, L.F., Fuxe, K., Benfenati, F., and Battistini, N. (1983). Neurotensin In Vitro Markedly Reduces the Affinity in Subcortical Limbic 3H-N-Propylnorapomorphine Binding Sites. Acta Physiol. Scand., 119:459–461.
Agnati, L.F., Fuxe, K., Battistini, N., and Benfenati, F. (1984). Aging Brain and Dopamine Receptors: Abnormal Regulation by CCK-8 of 3H-Spiperone Labeled Dopamine Receptors in Striatal Membranes. Acta. Physiol. Scand. 120:465–467.
Anderson, C.M., Bissette, G., Nemeroff, C.B., and Kilts, C.D. (1984). Microtopographic Distribution of Neurotensin and Catecholamine Concentrations at the Level of Individual Rat Brain Nuclei. Soc. Neurosci. Abs. 10:437.
Andrade, R. and Aghajanian, G.K. (1981). Neurotensin Selectively Activates Dopamine Neurons in the Substantia Nigra. Soc. Neurosci. Abs. 7:573.
Baldessarini, R.J. and Tarsy, D. (1980). Pathophysiologic basis of tardive dyskinesia. Adv. Biochem. Psychopharmacol. 24:451–455.
Beal, M.F. and Martin, J.B. (1984). Effects of Neuroleptic Drugs on Brain Somatostatin-Like-Immunoreactivity. Neurosci. Let. 47:125–130.
Bissette, G. and Nemeroff, C.B. (1984). Do Neuropeptide Systems Mediate Some of the Effects of Antipsychotic Drugs? In Endocoids. (eds. H. Lal, F. LaBella, and J. Lane). Alan R. Liss, Publishers, New York.
Bissette, G., Nemeroff, C.B., Decker, M.W., Kizer, J.S., Agid, Y., and Javoy-Agid, F. (1984a). Alterations in Regional Brain Concentrations of Neurotensin and Bombesin in Parkinson’s Disease. Ann. Neurol. (in press).
Bissette, G., Richardson, C., Kizer, J.S., and Nemeroff, C.B. (1984b). Ontogeny of Brain Neurotensin in the Rat: A Radioimmunoassay Study. J. Neurochem., 43:283–287.
Bunney, B.S. and Aghajanian, G.R. (1975). Evidence for Drug Actions on Both Pre- and Postsynaptic Receptors in the CNS. In Pre- and Post-Synaptic Receptors. (eds. E. Usdin and W.E. Bunney) Marcel Dekker, New York.
Carlsson, A. (1978). Mechanism of Action of Neuroleptic Drugs. In Psychopharmacology: A Generation of Progress. (eds. M.A. Lipton, A. Dimascio, and K.F. Killam) Raven Press, New York.
Chou, J., Tang, J., Yang, H-Y.T., and Costa, E. (1983). Increase of Striatal Met5-Enkephalin-Arg-Phe7 (YGGFMRF) Content Elicited by Long-Term Treatment with Haloperidol. J. Pharm. Exp. Ther. 229:171–174.
Dichiara, G., Porceddu, M.L., Spano, P.F., and Gessa, G.L. (1977). Haloperidol Increases and Apomorphine Decreases Striatal Dopamine Metabolism After Destruction of Striatal Dopamine-Sensitive Adenylate Cyclase by Kainic Acid. Brain Res. 130:374–382.
Emson, P.C., Goedert, M., Williams, B., Ninkovic, M., and Hunt, S.P. (1982). Neurotensin: Regional Distribution, Characterization, and Inactivation. In Neurotensin. a Brain and Gastrointestinal Peptide. (eds. C.B. Nemeroff and A.J. Prange, Jr.) N. Y. Academy of Sciences, New York.
Ervin, G.M., Birkemo, L.S., Nemeroff, C.B. and Prange, A.J. (1981). Neurotensin Blocks Certain Amphetamine-induced Behaviors. Nature 291:73–76.
Frey, P. (1983). Cholecystokinin Octapeptide Levels in Rat Brain are Changed After Subchronic Neuroleptic TReatment. Eur. J. Pharmacol. 95:87–92.
Fuxe, K., Agnati, L.F., Benfenati, F., Celani, M., Zini, I., Zoli, M., and Mutt, V. (1983). Evidence for the Existence of Receptor-Receptor Interactions in the Central Nervous System. Studies on the Regulation of Monoamine Receptors by Neuropeptides. J. Neural Transmission. Suppl. 19:165–179.
Garcia-Sevilla, J.A., Magnusson, T., Carlsson, A., Leban, J., and Folkgrs, K. (1978). Neurotensin and Its Amide Analogue [Gln4]-Neurotensin: Effects on Brain Monoamine Turnover. Naunyn-Schmiedeberg’s Arch. Pharmacol. 305:213–218.
Gerlach, J., Thorse, K., and Fog, R. (1975). Extrapyramidal Reactions and Amine Metabolites in Cerebrospinal Fluid During Haloperidol and Clozapine Treatment of Schizophrenic Patients. Psychopharmacologia (Berl.) 40:341–350.
Gilbert, J.A., McKinney, M., and Richelson, E. (1984). Neurotensin Stimulates Cyclic GMP Fromation in Neuroblastoma Clone N1E-115 and Rat Cerebellum. Soc. Neurosci. Abs. 10:378.
Gilbert, J.A. and Richelson, E. (1984). Neurotensin Stimulates Formation of Cyclic GMP in Murine Neuroblastoma Clone N1E-115. Eur. J. Pharmacol., 99:245–246.
Glimcher, P.W., Margolin, D.H., Giovino, A.A., and Hoebel, B.G. (1984). Neurotensin: A New ‘Reward Peptide’. Brain Res. 291:119–124.
Goedert, M. (1984). Neurotensin — a status report. Trends in Neurosci. 7:3–5.
Goedert, M., Pittaway, K., and Emson, P.C. (1984a). Neurotensin Receptors in the Rat Striatum: lesion studies. Brain Res. 299:164–168.
Goedert, M., Pittaway, K. Williams, B.J., and Emson, P.C. (1984b). Specific Binding of Tritiated Neurotensin to Rat Brain Membranes: Characterization and Regional Distribution. Brain Res. 304:71–81.
Goedert, M., Mantyh, P.W., Emson, P.C., and Hunt, S.P. (1984c). Inverse Relationship Between Neurotensin Receptors and Neurotensin-line Immunoreactivity in Cat Striatum. Nature, 307:543–546.
Govoni, S., Hong, J.S., Yang, Y.-H.T., and Costa, E. (1980). Increase of Neurotensin Content Elicited by Neuroleptics in Nucleus Accumbens. J. Pharm. Exp. Ther. 215:413–417.
Haubrich, D.R., Martin, G.E., Martin, E., Pflueger, A.B., and Williams, M. (1982). Neurotensin Effects on Brain Dopaminergic Systems. Brain Res. 231:216–221.
Henry, J.L. (1982). Electrophysiological Studies on the Neuroactive Properties of Neurotensin. In Neurotensin. a Brain and Gastrointestinal Peptide. (eds. C.B. Nemeroff and A.J. Prange, Jr.) N. Y. Academy of Sciences, New York.
Hernandez, D.E., Richardson, C.M., Nemeroff, C.B., Orlando, R.C., St-Pierre, S., Rioux, F., and Prange, A.J. (1984). Evidence for Biological Activity of Two N-Terminal Fragments of Neurotensin, Neurotensin1–8 and Neurotensin1–10. Brain Res. 301:153–156.
Hokfelt, T., Everitt, B.J., Theodorsson-Norheim, E., and Goldstein, M. (1984). Occurrence of Neurotensin-like Immunoreactivity in Subpopulations of Hypothalamic, Mesencephalic, and Medullary Catecholamine Neurons. J. Comp. Neurol. 222: 543–559.
Hong, J.S., Yang, Y.-H.T., Fratta, W., and Costa, E. (1978). Rat Striatal Methionine-Enkephalin Content After Chronic Treatment with Cataleptogenic and Noncataleptogenic Antischizophrenic Drugs. J. Pharm. Exp. Ther. 205:141–147.
Hong, J.-S., Tilson, H.A., and Yoshikawa, R. (1982). Effects of Lithium and Haloperidol Administration on the Rat Brain Levels of Substance P. J. Pharm. Exp. Ther. 224:590–593.
Ibata, Y., Okamura, F.H., Rawakami, T., Tanaka, M., Obata, H.L., Tsuto, O.T., Terubayashi, H., Yanaibara, C., and Yanaihara, N. (1983). Coexistence of Dopamine and Neurotensin in Hypothalamic Arcuate and Periventricular Neurons. Brain Res. 269:177–179.
Iversen, L.L., Iversen, S.D., Bloom, F., Douglas, C., Brown, M., and Vale, W. (1978). Calcium-Dependent Release of Somatostatin and Neurotensin from Rat Brain In Vitro. Nature 273:161.
Jennes, L., Stumpf, W.E., and Kalivas, P.W. (1982). Neurotensin: Topographical Distribution in Rat Brain by Immunohistochemistry. J. Comp. Neurol. 210:211–224.
Jolicoeur, F.B. and Barbeau, A. (1982). Pharmacological Evidence for a Heterogeneity of Receptors Underlying Various Central and Peripheral Effects of Neurotensin. In Neurotensin. a Brain and Gastrointestinal Peptide. (eds. C.B. Nemeroff and A. J. Prange, Jr.) N. Y. Academy of Sciences, New York.
Jolicoeur, F.B., De Michele, G., and Barbeau, A. (1983). Neurotensin Affects Hyperactivity but not Stereotypy Induced by Pre and Post Synaptic Dopaminergic Stimulation. Neurosci. Biobehav. Rev. 7:385–390.
Kalivas, P.W., Nemeroff, C.B., and Prange, A.J. (1981). Increase in Spontaneous Motor Activity Following Infusion of Neurotensin into the Ventral Tegmental Area. Brain Res. 229:525–529.
Kalivas, P.W., Nemeroff, C.B., and Prange, A.J., Jr. (1982a). Neuroanatomical Site Specific Modulation of Spontaneous Motor Activity by Neurotensin. Eur. J. Pharm. 78:471–474.
Kalivas, P.W., Nemeroff, C.B. and Prange, A.J. (1982b) Neuroanatomical Sites of Action of Neurotensin. In Neurotensin. a Brain and Gastrointestinal Peptide. (eds. C.B. Nemeroff and A. J. Prange, Jr.) N. Y. Academy of Sciences, New York.
Kalivas, P.W., Burgess, S.K., Nemeroff, C.B., and Prange, A.J., Jr. (1983). Behavioral and Neurochemical Effects of Neurotensin Microinjection into the Ventral Tegmental Area of the Rat. Neurosci. 8:495–505.
Kalivas, P.W. (1984). Neurotenain in the Ventromedial Mesencephalon of the Rat: Anatomical and Functional Considerations. J. Comp. Neurol. 226:495–507.
Kalivas, P.W., Nemeroff, C.B., and Prange, A.J., Jr. (1984). Neurotensin Microinjection into the Nucleus Accumbens Antagonizes Dopamine-Induced Increase in Locomotion and Rearing. Neurosci. 11:919–930.
Kebabian, J.W. and Calne, D.B. (1979). Multiple Receptors for Dopamine. Nature 277:93–96.
Kilts, C.D., Gooch, M.D. and Knopes, R.D. (1984). Quantitation of Plasma Catecholamines by On-Line Trace Enrichment High Performance Liquid Chromatography with Electrochemical Detection. J. Neurosci. Methods, (in press).
Kobayashi, R.M., Brown, M., and Vale, W. (1977). Regional Distribution of Neurotensin and Somatostatin in Rat Brain. Brain Res. 126:584–588.
Lindvall, O. and Bjorklund, A. (1983). Dopamine- and Norepinephrine-Containing Neuron Systems: Their Anatomy in the Rat Brain. In Chemical Neuroanatomy. (ed. by P. Emson). Raven Press, New York.
Loosen, P.T., Nemeroff, C.B., Bissette, G., Prange, A.J., Jr., Burnett, G.B., and Lipton, M.A. (1978). Neurotensin-induced Hypothermia in the Rat: Structure-activity Studies. Neuropharmacology 17:109–113.
Manberg, P.J., Youngblood, W.W., Nemeroff, C.B., Rossor, M., Iversen, L.L., Prange, A.J., Jr., and Kizer, J.S. (1982). Regional Distribution of Neurotensin in Human Brain. J. Neurochem. 38:1777–1780.
Marwaha, J., Hoffer, B., and Freedman, R. (1980). Electrophysiological Actions of Neurotensin in Rat Cerebellum. Reg. Peptides 1:115–125.
McCarthy, P.S., Waller, R.J., Yajima, H., Mitagawa, K., and Woodruff, G.H. (1979). The Action of Neurotensin on Neurons in the Nucleus Accumbens and Cerebellum of the Rat. Gen. Pharmacol. 10:331–333.
Meltzer, H.Y. and Stahl, S.M. (1976). The dopamine hypothesis of schizophrenia: A review. Schizophrenia Bull. 2:19–76.
Miletic, V. and Randic, M. (1979). Neurotensin Excites Cat Spinal Neurones Located in Laminae I–III. Brain Res. 169:600–604.
Nemeroff, C.B., Hernandez, D.E., Luttinger, D., Kalivas, P., and Prange, A.J., Jr. (1982a). Interactions of Neurotensin with Brain Dopamine Systems. In Neurotensin. a Brain and Gastrointestinal Peptide. (eds. C.B. Nemeroff and A. J. Prange, Jr.) N. Y. Academy of Sciences, New York.
Nemeroff, C.B., Hernandez, D.E., Orlando, R.C., and Prange, A.J., Jr. (1982b). Cytoprotective Effect of Centrally Administered Neurotensin on Stress-Induced Gastric Ulcers. Amer. J. Physiol. 242:342–346.
Nemeroff, C.B., Luttinger, D., Hernandez, D.E., Mailman, R.B., Mason, G.A., Davis, S.D., Widerlov, E., Frye, G.D., Kilts, C.D., Beaumont, K., Breese, G.R., and Prange, A.J., Jr. (1983a). Interactions of Neurotensin with Brain Dopamine Systems: Biochemical and Behavioral Studies. J. Pharmacol. Exp. Ther. 225:337–345.
Nemeroff, C.B., Youngblood, W., Manberg, P.J., Prange, A.J., Jr., and Kizer, J.S. (1983b). Regional Brain Concentrations of Neuropeptides in Huntington’s Chorea and Schizophrenia. Science 221:972–975.
Nemeroff, C.B., Kalivas, P.W., and Prange, A.J., Jr. (1984). Interaction of Neurotensin and Dopamine in Limbic Structures. (eds. E. Usdin, A. Carlsson, A. Dahlstrom and J. Engel) Catecholamines: Neuropharmacolosty and Central Nervous System — Theoretical Aspects. Alan R. Liss, New York.
Okuma, Y., Fukuda, Y., and Osumi, Y. (1983). Neurotensin Potentiates the Potassium-Induced Release of Endogenous Dopamine From Rat Striatal Slices. Eur. J. Pharmacol. 93:27–33.
Palacios, J.M. and Kuhar, M.J. (1981). Neurotensin Receptors are Located on Dopamine-containing Neurones in Rat Midbrain. Nature 294:587–589.
Palkovits, M. (1973). Isolated Removal of Hypothalamic or Other Brain Nuclei of the Rat. Brain Res. 59:449–450.
Phillis, J.W. and Kirkpatrick, J.R. (1980). The Actions of Motilin, Leutinizing Hormone Releasing Hormone, Cholecystokinin, Somatostatin, Vasoactive Intestinal Peptide and Other Peptides on Rat Cerebral Cortical Neurons. Can. J. Physiol. Pharmacol. 58:612–623.
de Quidt, M. and Emson, P.C. (1983). Neurotensin Facilitates Dopamine Release In Vitro From Rat Striatal Slices. Brain Res. 274:376–380.
Quirion, R., Everist, H.D., and Pert, A. (1982). Nigrostriatal Dopamine Terminals Bear Neurotensin Receptors but the Mesolimbic Do Not. Soc. Neurosci. Abs. 8:582.
Reches, A., Burke, R.E., Jiang, D., Wagner, H.R., and Fahn, S. (1982). The Effect of Neurotensin on Dopaminergic Neurons in Rat Brain. In Neurotensin, a Brain and Gastrointestinal Peptide. (eds. C.B. Nemeroff and A.J. Prange, Jr.) N. Y. Academy of Sciences, New York.
Sawada, S., Takada, S., and Yamamoto, C. (1980). Electrical Activity Recorded from Thin Sections of the Bed Nucleus of the Stria Terminalis, and the Effects of Neurotensin. Brain Res. 188:578–581.
Seeman, P. (1980). Dopamine Receptors. Pharmacol. Rev. 3:229–313.
Snyder, S.H. (1972). Catecholamines in the Brain as mediators of Amphetamine psychosis. Arch. Gen. Psychiatry 27: 169–179.
Stevens, J.R. (1973). An anatomy of Schizophrenia? Arch. Gen. Psychiatry 29: 177–189.
Uhl, G.R. and Kuhar, M.J. (1984). Chronic Neuroleptic Treatment Enhances Neurotensin Receptor Binding in Human and Rat Substantia Nigra. Nature 309:350–352.
Walters, J.R. and Roth, R.H. (1976). Dopaminergic Neurons: An In Vivo System for Measuring Drug Interactions with Presynaptic Receptors. Naunyn-Schmiedeberg’s Arch. Pharmacol. 296:5–14.
Widerlov, E., Kilts, C.D., Mailman, R.B., Nemeroff, C.B., Mc Cown, T.J., Prange, A.J., Jr., and Breese, G.R. (1982a). Increase in Dopamine Metabolites in Rat Brain by Neurotensin. J. Pharmacol. Exp. Ther. 222:1–6.
Widerlov, E., Lindstrom, L. H., Besev, G., Manberg, P.J., Nemeroff, C.B., Breese, G.R., Kizer, J.S., and Prange, A.J., Jr. (1982b). Subnormal CSF Levels of Neurotensin in a Subgroup of Schizophrenic Patients: Normalization after Neuroleptic Treatment. Am. J. Psychiatr. 139:1122–1126.
Young, W.S., III, Uhl, G.R., and Kuhar, M.J. (1978). Iontophoresis of Neurotensin in the Area of the Locus Coeruleus. Brain Res. 150:431–435.
Young, W.S., III and Kuhar, M.J. (1979). Neurotensin Receptors: Autoradiographic Localization in Rat CNS. Eur. J. Pharmacol. 59:161–163.
Editor information
Editors and Affiliations
Copyright information
© 1986 The Contributors
About this chapter
Cite this chapter
Kilts, C.D., Bissette, G., Cain, S.T., Skoog, K.M., Nemeroff, C.B. (1986). Neuropeptide-Dopamine Interactions: Focus on Neurotensin. In: Woodruff, G.N., Poat, J.A., Roberts, P.J. (eds) Dopaminergic Systems and their Regulation. Satellite Symposia of the IUPHAR 9th International Congress of Pharmacology. Palgrave Macmillan, London. https://doi.org/10.1007/978-1-349-07431-0_15
Download citation
DOI: https://doi.org/10.1007/978-1-349-07431-0_15
Publisher Name: Palgrave Macmillan, London
Print ISBN: 978-1-349-07433-4
Online ISBN: 978-1-349-07431-0
eBook Packages: MedicineMedicine (R0)